How NeuroMetrix Inc. (NASDAQ:NURO) could change?


Here is a look at the scorecard of NeuroMetrix Inc. (NASDAQ:NURO) for the most recent quarter as well as analyst estimates for the coming periods.

The company generated sales of 4.31M%, implying an increase of 0.47% compared to a similar quarter a year earlier.

To achieve the reported sales of 4.31M% for the quarter, the company incurred $2.7M in cost of goods. Therefore, after taking into account the cost of sales, NeuroMetrix Inc. emerged with a gross income of $1.61M.

Recently, NeuroMetrix, Inc. (NASDAQ:NURO) announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain – as well as the rapidly growing user base of the company’s Quell(R) Wearable Pain Relief Technology(TM).

Let?s look into the technical of the stock

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

NeuroMetrix Inc. also incurred other expenses in the course of operation. So after taking those into account as well, it exited the quarter with EPS of $(7.28). The company had 1M diluted outstanding shares at the end of the quarter.

For the next quarter, analysts on the average are modeling EPS of $-1.74.

NeuroMetrix Inc.?s cash balance at the end of the most recent quarter was 6.9M%. The company generated free cash flow of $(3.35M) during the quarter, with net operating cash flow being $(3.35M). Net change in cash was $2.95M.

What is Wall Street thinking about NeuroMetrix Inc.? So far 1 analysts have weighed on the stock, and from that it has average analyst recommendation of Buy and average price target of $16.00. To put the analyst recommendation into perspective, recommendation in the range of 1.00 – 1.24 implies a BUY recommendation, while 1.25 – 1.74 implies OVERWEIGHT. HOLD recommendation is represented by 1.75 ? 2.24, UNDERWEIGHT is represented by 2.25 – 2.74 while SELL is represented by 2.75 – 3.00.

Does NeuroMetrix Inc. have a healthy balance sheet? A look at the company’s balance sheet at the end of the most recent quarter shows that it reflects total assets of $11.09M, offset by total liabilities of $3.24M.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.